Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis

LH Eusebi, R Ratnakumaran, Y Yuan… - Gut, 2018‏ - gut.bmj.com
Objectives Gastro-oesophageal reflux symptoms are common in the community, but there
has been no definitive systematic review and meta-analysis of data from all studies to …

Oesophageal carcinoma

A Pennathur, MK Gibson, BA Jobe, JD Luketich - The Lancet, 2013‏ - thelancet.com
Oesophageal carcinoma affects more than 450 000 people worldwide and the incidence is
rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal …

Global, regional and national burden of gastroesophageal reflux disease, 1990–2019: update from the GBD 2019 study

D Zhang, S Liu, Z Li, R Wang - Annals of medicine, 2022‏ - Taylor & Francis
Background Because trends in the epidemiology and burden of gastroesophageal reflux
disease (GERD) are changing, reinvestigating the geographical differences and trend …

Guidelines for the diagnosis and management of gastroesophageal reflux disease

PO Katz, LB Gerson, MF Vela - … journal of the American College of …, 2013‏ - journals.lww.com
Gastroesophageal reflux disease (GERD) is arguably the most common disease
encountered by the gastroenterologist. It is equally likely that the primary care providers will …

Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis

AC Ford, A Marwaha, R Sood, P Moayyedi - Gut, 2015‏ - gut.bmj.com
Objectives Many cross-sectional surveys have reported the prevalence of uninvestigated
dyspepsia, but there has been no recent systematic review of data from all studies to …

Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms

SD Delshad, CV Almario, WD Chey, BMR Spiegel - Gastroenterology, 2020‏ - Elsevier
Background & aims There are few data on the prevalence of gastroesophageal reflux
disease (GERD) in the United States. We performed a population-based study to determine …

Gastroparesis: a turning point in understanding and treatment

M Grover, G Farrugia, V Stanghellini - Gut, 2019‏ - gut.bmj.com
Gastroparesis is defined by delayed gastric emptying (GE) and symptoms of nausea,
vomiting, bloating, postprandial fullness, early satiety and abdominal pain. Most common …

A luminal unfolding microneedle injector for oral delivery of macromolecules

A Abramson, E Caffarel-Salvador, V Soares… - Nature medicine, 2019‏ - nature.com
Insulin and other injectable biologic drugs have transformed the treatment of patients
suffering from diabetes,, yet patients and healthcare providers often prefer to use and …

Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study

NJ Talley, GR Locke, YA Saito, AE Almazar, EP Bouras… - Gastroenterology, 2015‏ - Elsevier
Background & Aims Antidepressants are frequently prescribed to treat functional dyspepsia
(FD), a common disorder characterized by upper abdominal symptoms, including discomfort …

The functional gastrointestinal disorders and the Rome III process

DA Drossman - gastroenterology, 2006‏ - gastrojournal.org
Throughout recorded history, and alongside struc-tural diseases of the intestinal tract, are
maladies that have produced multiple symptoms of pain, nausea, vomiting, bloating …